Sale!

COG5 Gene Glycosylation Disorder Type 2I Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COG5 Gene Glycosylation Disorder Type 2I Genetic Test is a specialized diagnostic tool designed to identify mutations in the COG5 gene, which are associated with Congenital Disorders of Glycosylation (CDG). Type 2I CDG is a rare genetic condition that affects the normal process of adding sugar chains to proteins (glycosylation), crucial for various bodily functions. Symptoms of this disorder can range from mild to severe and may include developmental delay, neurological issues, and abnormalities in organ function.

This genetic test involves analyzing the patient’s DNA to detect specific mutations in the COG5 gene that are known to cause the disorder. Early diagnosis through this test can be pivotal in managing symptoms and improving the quality of life for affected individuals.

The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the COG5 Gene Glycosylation Disorder Type 2I Genetic Test is set at 4400 AED. Given the complexity of the condition and the specialized nature of the test, this investment can be crucial for families seeking answers to unexplained symptoms related to glycosylation disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COG5 Gene Glycosylation Disorder Type 2I Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for COG5 Gene Glycosylation disorder type 2I NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2I

Test Details:

COG5 Gene Glycosylation Disorder Type 2I NGS Genetic Test is a genetic test that focuses on the COG5 gene. This gene is responsible for encoding a protein involved in the process of glycosylation, which is the addition of sugar molecules to proteins and lipids. Glycosylation is a crucial process for many cellular functions, including protein folding, stability, and cell-to-cell communication.

Mutations in the COG5 gene can disrupt the glycosylation process, leading to a glycosylation disorder known as Type 2I. The NGS (Next-Generation Sequencing) technique is used in this genetic test to analyze the DNA sequence of the COG5 gene. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations in the COG5 gene.

This genetic test can help diagnose individuals suspected of having Type 2I glycosylation disorder. It can also be used for carrier testing in individuals with a family history of the disorder. Early diagnosis through genetic testing can help guide appropriate management and treatment strategies for affected individuals.

Test Name COG5 Gene Glycosylation disorder type 2I Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COG5 Gene Glycosylation disorder type 2I NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2I
Test Details

COG5 Gene Glycosylation Disorder Type 2I NGS Genetic Test is a genetic test that focuses on the COG5 gene. This gene is responsible for encoding a protein involved in the process of glycosylation, which is the addition of sugar molecules to proteins and lipids.

Glycosylation is a crucial process for many cellular functions, including protein folding, stability, and cell-to-cell communication. Mutations in the COG5 gene can disrupt the glycosylation process, leading to a glycosylation disorder known as Type 2I.

The NGS (Next-Generation Sequencing) technique is used in this genetic test to analyze the DNA sequence of the COG5 gene. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations in the COG5 gene.

This genetic test can help diagnose individuals suspected of having Type 2I glycosylation disorder. It can also be used for carrier testing in individuals with a family history of the disorder. Early diagnosis through genetic testing can help guide appropriate management and treatment strategies for affected individuals.